Clinical trial
T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type…
NCT00212329 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00212329 |
|---|---|
| Title | T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus |
| Official title | A Comparative Study Between the Cytokine Elispot, Tetramer, Immunoblot, and T Cell Proliferation Assays Using Fresh Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Procedure |
| Interventions | T Cell Proliferation and Autoreactivity Assays, Cellular Immunoblot Assays, Tetramer Studies, Cytokine ELISPOT |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 13, 2016 |
| Countries | United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: